Sphere Fluidics in-licenses international portfolio of 21 patents in picodroplet technology

Sphere Fluidics has now in-licensed a major portfolio of patents enabling it to broaden its activities in the provision of picodroplet-related services and products. “These patents are complementary to our current, in-house portfolio and means we can extend our business activities in our chosen markets” said Dr Frank F. Craig, CEO of Sphere Fluidics. “We are continuing to build our IP portfolio and plan to make it one of the strongest in its Field”.